Not checkedNot checked for notices yet.
Correction: AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia.
Ji-jing Pang, Wen-Tao Deng, Xufeng Dai and 14 more
PLoS ONE · 2014
doi:10.1371/annotation/29fb0ebc-b1c7-4d05-bd70-d29b10299df4 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Achromatopsia is a rare autosomal recessive disorder which shows color blindness, severely impaired visual acuity, and extreme sensitivity to bright light.Mutations in the alpha subunits of the cone cyclic nucleotide-gated channels (CNGA3) are responsible for about 1/4 of achromatopsia in the U.S. and Europe.Here, we test whether gene replacement therapy using an AAV5 vector could restore cone-mediated function and arrest cone degeneration in the cpfl5 mouse, a naturally occurring mouse model of achromatopsia with a CNGA3 mutation.We show that gene therapy leads to significant rescue of cone-mediated ERGs, normal visual acuities and contrast sensitivities.Normal expression and outer segment localization of both M-and S-opsins were maintained in treated retinas.The therapeutic effect of treatment lasted for at least 5 months post-injection.This study is the first demonstration of substantial, relatively long-term restoration of cone-mediated light responsiveness and visual behavior in a naturally occurring mouse model of CNGA3 achromatopsia.The results provide the foundation for development of an AAV5-based gene therapy trial for human CNGA3 achromatopsia.
Abstract licence: CC BY
References36
36 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.